Trial intelligence / Profile preview

Recombinant Human Prolactin for lactation augmentation

NCT00438490Phase 2Completed

Sponsor
Massachusetts General Hospital
Start
Apr 2002
Primary completion
Mar 2011
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 2 trial of recombinant human prolactin in lactation insufficiency, sponsored by Massachusetts General Hospital. Started Apr 2002; status: completed.

02

Drugs

recombinant human prolactin
03

Conditions

lactation insufficiency

Beyond the preview

Go deeper on NCT00438490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00438490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call